Immuneering (IMRX) Leases (2020 - 2024)
Historic Leases for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $3.7 million.
- Immuneering's Leases fell 821.06% to $3.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.7 million, marking a year-over-year decrease of 821.06%. This contributed to the annual value of $4.0 million for FY2023, which is 934.83% down from last year.
- Immuneering's Leases amounted to $3.7 million in Q3 2024, which was down 821.06% from $3.8 million recorded in Q2 2024.
- Immuneering's 5-year Leases high stood at $5.3 million for Q4 2021, and its period low was $537181.0 during Q3 2021.
- Moreover, its 5-year median value for Leases was $4.1 million (2023), whereas its average is $3.6 million.
- Per our database at Business Quant, Immuneering's Leases skyrocketed by 76840.19% in 2021 and then plummeted by 1721.22% in 2022.
- Quarter analysis of 5 years shows Immuneering's Leases stood at $613103.0 in 2020, then soared by 768.4% to $5.3 million in 2021, then fell by 17.21% to $4.4 million in 2022, then decreased by 9.35% to $4.0 million in 2023, then decreased by 6.19% to $3.7 million in 2024.
- Its last three reported values are $3.7 million in Q3 2024, $3.8 million for Q2 2024, and $3.9 million during Q1 2024.